
An annuloplasty system is a medical device used in cardiac surgery to repair a damaged or dysfunctional heart valve, typically the mitral or tricuspid valve. The goal of annuloplasty is to restore the normal size, shape, and function of the valve's annulus, which is the ring-like structure that supports the valve leaflets.
The global Annuloplasty System market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The “Annuloplasty System Industry Forecast” looks at past sales and reviews total world Annuloplasty System sales in 2023, providing a comprehensive analysis by region and market sector of projected Annuloplasty System sales for 2024 through 2030. With Annuloplasty System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Annuloplasty System industry.
This Insight Report provides a comprehensive analysis of the global Annuloplasty System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Annuloplasty System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Annuloplasty System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Annuloplasty System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Annuloplasty System.
United States market for Annuloplasty System is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Annuloplasty System is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Annuloplasty System is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Annuloplasty System players cover Edwards Lifesciences, Medtronic, Abbott (formerly St. Jude Medical), Sorin Group (now part of LivaNova), Boston Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Annuloplasty System market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Mitral Valve Repair
Tricuspid Valve Repair
Aortic Valve Repair
Segmentation by Application:
Hospitals
Ambulatory Surgical Centers
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Edwards Lifesciences
Medtronic
Abbott (formerly St. Jude Medical)
Sorin Group (now part of LivaNova)
Boston Scientific
Valtech Cardio (acquired by Edwards Lifesciences)
NeoChord
Corcym
Labcor Laboratories Ltda.
AFFLUENT MEDICAL
Valcare Medical
Braile Biomédica
Micro Interventional Devices, Incorporated
Key Questions Addressed in this Report
What is the 10-year outlook for the global Annuloplasty System market?
What factors are driving Annuloplasty System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Annuloplasty System market opportunities vary by end market size?
How does Annuloplasty System break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Annuloplasty System Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Annuloplasty System by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Annuloplasty System by Country/Region, 2019, 2023 & 2030
2.2 Annuloplasty System Segment by Type
2.2.1 Mitral Valve Repair
2.2.2 Tricuspid Valve Repair
2.2.3 Aortic Valve Repair
2.3 Annuloplasty System Sales by Type
2.3.1 Global Annuloplasty System Sales Market Share by Type (2019-2024)
2.3.2 Global Annuloplasty System Revenue and Market Share by Type (2019-2024)
2.3.3 Global Annuloplasty System Sale Price by Type (2019-2024)
2.4 Annuloplasty System Segment by Application
2.4.1 Hospitals
2.4.2 Ambulatory Surgical Centers
2.4.3 Others
2.5 Annuloplasty System Sales by Application
2.5.1 Global Annuloplasty System Sale Market Share by Application (2019-2024)
2.5.2 Global Annuloplasty System Revenue and Market Share by Application (2019-2024)
2.5.3 Global Annuloplasty System Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Annuloplasty System Breakdown Data by Company
3.1.1 Global Annuloplasty System Annual Sales by Company (2019-2024)
3.1.2 Global Annuloplasty System Sales Market Share by Company (2019-2024)
3.2 Global Annuloplasty System Annual Revenue by Company (2019-2024)
3.2.1 Global Annuloplasty System Revenue by Company (2019-2024)
3.2.2 Global Annuloplasty System Revenue Market Share by Company (2019-2024)
3.3 Global Annuloplasty System Sale Price by Company
3.4 Key Manufacturers Annuloplasty System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Annuloplasty System Product Location Distribution
3.4.2 Players Annuloplasty System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Annuloplasty System by Geographic Region
4.1 World Historic Annuloplasty System Market Size by Geographic Region (2019-2024)
4.1.1 Global Annuloplasty System Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Annuloplasty System Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Annuloplasty System Market Size by Country/Region (2019-2024)
4.2.1 Global Annuloplasty System Annual Sales by Country/Region (2019-2024)
4.2.2 Global Annuloplasty System Annual Revenue by Country/Region (2019-2024)
4.3 Americas Annuloplasty System Sales Growth
4.4 APAC Annuloplasty System Sales Growth
4.5 Europe Annuloplasty System Sales Growth
4.6 Middle East & Africa Annuloplasty System Sales Growth
5 Americas
5.1 Americas Annuloplasty System Sales by Country
5.1.1 Americas Annuloplasty System Sales by Country (2019-2024)
5.1.2 Americas Annuloplasty System Revenue by Country (2019-2024)
5.2 Americas Annuloplasty System Sales by Type (2019-2024)
5.3 Americas Annuloplasty System Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Annuloplasty System Sales by Region
6.1.1 APAC Annuloplasty System Sales by Region (2019-2024)
6.1.2 APAC Annuloplasty System Revenue by Region (2019-2024)
6.2 APAC Annuloplasty System Sales by Type (2019-2024)
6.3 APAC Annuloplasty System Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Annuloplasty System by Country
7.1.1 Europe Annuloplasty System Sales by Country (2019-2024)
7.1.2 Europe Annuloplasty System Revenue by Country (2019-2024)
7.2 Europe Annuloplasty System Sales by Type (2019-2024)
7.3 Europe Annuloplasty System Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Annuloplasty System by Country
8.1.1 Middle East & Africa Annuloplasty System Sales by Country (2019-2024)
8.1.2 Middle East & Africa Annuloplasty System Revenue by Country (2019-2024)
8.2 Middle East & Africa Annuloplasty System Sales by Type (2019-2024)
8.3 Middle East & Africa Annuloplasty System Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Annuloplasty System
10.3 Manufacturing Process Analysis of Annuloplasty System
10.4 Industry Chain Structure of Annuloplasty System
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Annuloplasty System Distributors
11.3 Annuloplasty System Customer
12 World Forecast Review for Annuloplasty System by Geographic Region
12.1 Global Annuloplasty System Market Size Forecast by Region
12.1.1 Global Annuloplasty System Forecast by Region (2025-2030)
12.1.2 Global Annuloplasty System Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Annuloplasty System Forecast by Type (2025-2030)
12.7 Global Annuloplasty System Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Edwards Lifesciences
13.1.1 Edwards Lifesciences Company Information
13.1.2 Edwards Lifesciences Annuloplasty System Product Portfolios and Specifications
13.1.3 Edwards Lifesciences Annuloplasty System Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Edwards Lifesciences Main Business Overview
13.1.5 Edwards Lifesciences Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Annuloplasty System Product Portfolios and Specifications
13.2.3 Medtronic Annuloplasty System Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 Abbott (formerly St. Jude Medical)
13.3.1 Abbott (formerly St. Jude Medical) Company Information
13.3.2 Abbott (formerly St. Jude Medical) Annuloplasty System Product Portfolios and Specifications
13.3.3 Abbott (formerly St. Jude Medical) Annuloplasty System Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Abbott (formerly St. Jude Medical) Main Business Overview
13.3.5 Abbott (formerly St. Jude Medical) Latest Developments
13.4 Sorin Group (now part of LivaNova)
13.4.1 Sorin Group (now part of LivaNova) Company Information
13.4.2 Sorin Group (now part of LivaNova) Annuloplasty System Product Portfolios and Specifications
13.4.3 Sorin Group (now part of LivaNova) Annuloplasty System Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Sorin Group (now part of LivaNova) Main Business Overview
13.4.5 Sorin Group (now part of LivaNova) Latest Developments
13.5 Boston Scientific
13.5.1 Boston Scientific Company Information
13.5.2 Boston Scientific Annuloplasty System Product Portfolios and Specifications
13.5.3 Boston Scientific Annuloplasty System Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Boston Scientific Main Business Overview
13.5.5 Boston Scientific Latest Developments
13.6 Valtech Cardio (acquired by Edwards Lifesciences)
13.6.1 Valtech Cardio (acquired by Edwards Lifesciences) Company Information
13.6.2 Valtech Cardio (acquired by Edwards Lifesciences) Annuloplasty System Product Portfolios and Specifications
13.6.3 Valtech Cardio (acquired by Edwards Lifesciences) Annuloplasty System Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Valtech Cardio (acquired by Edwards Lifesciences) Main Business Overview
13.6.5 Valtech Cardio (acquired by Edwards Lifesciences) Latest Developments
13.7 NeoChord
13.7.1 NeoChord Company Information
13.7.2 NeoChord Annuloplasty System Product Portfolios and Specifications
13.7.3 NeoChord Annuloplasty System Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 NeoChord Main Business Overview
13.7.5 NeoChord Latest Developments
13.8 Corcym
13.8.1 Corcym Company Information
13.8.2 Corcym Annuloplasty System Product Portfolios and Specifications
13.8.3 Corcym Annuloplasty System Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Corcym Main Business Overview
13.8.5 Corcym Latest Developments
13.9 Labcor Laboratories Ltda.
13.9.1 Labcor Laboratories Ltda. Company Information
13.9.2 Labcor Laboratories Ltda. Annuloplasty System Product Portfolios and Specifications
13.9.3 Labcor Laboratories Ltda. Annuloplasty System Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Labcor Laboratories Ltda. Main Business Overview
13.9.5 Labcor Laboratories Ltda. Latest Developments
13.10 AFFLUENT MEDICAL
13.10.1 AFFLUENT MEDICAL Company Information
13.10.2 AFFLUENT MEDICAL Annuloplasty System Product Portfolios and Specifications
13.10.3 AFFLUENT MEDICAL Annuloplasty System Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 AFFLUENT MEDICAL Main Business Overview
13.10.5 AFFLUENT MEDICAL Latest Developments
13.11 Valcare Medical
13.11.1 Valcare Medical Company Information
13.11.2 Valcare Medical Annuloplasty System Product Portfolios and Specifications
13.11.3 Valcare Medical Annuloplasty System Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Valcare Medical Main Business Overview
13.11.5 Valcare Medical Latest Developments
13.12 Braile Biomédica
13.12.1 Braile Biomédica Company Information
13.12.2 Braile Biomédica Annuloplasty System Product Portfolios and Specifications
13.12.3 Braile Biomédica Annuloplasty System Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Braile Biomédica Main Business Overview
13.12.5 Braile Biomédica Latest Developments
13.13 Micro Interventional Devices, Incorporated
13.13.1 Micro Interventional Devices, Incorporated Company Information
13.13.2 Micro Interventional Devices, Incorporated Annuloplasty System Product Portfolios and Specifications
13.13.3 Micro Interventional Devices, Incorporated Annuloplasty System Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Micro Interventional Devices, Incorporated Main Business Overview
13.13.5 Micro Interventional Devices, Incorporated Latest Developments
14 Research Findings and Conclusion
*If Applicable.
